CliffBio
small molecule

QDOLO

TRAMADOL HYDROCHLORIDE

Loss of exclusivitySeptember 2040latest FDA-listed patent expiry
CompanyRosemont Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameQDOLO
Active ingredientTRAMADOL HYDROCHLORIDE
Strength5MG/ML
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalSeptember 2020
Marketing statusDISCN

Listed patents

PatentExpiresType
11103452September 2040product
11752103September 2040product

More from Rosemont Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

QDOLO patent cliff — loss of exclusivity September 2040 | CliffBio